Radiotherapy as a partner for immunotherapy in pancreatic cancer: current landscape and future directions.

Front Oncol · 2026 · PMC13044025 · PMID 41939454

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

In the immune-positive group, the median RFS had not yet been reached, while the immune-negative group had an RFS of 13.4 months, with a significant trend difference ( 24 ).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.